Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Wall St. ends flat in short session, Dow ekes out record close

Published 12/24/2014, 01:24 PM
Updated 12/24/2014, 01:24 PM
© Reuters. The exterior of the New York Stock Exchange is pictured with a Christmas tree in front of it in the Manhattan Borough of New York

By Ryan Vlastelica

NEW YORK (Reuters) - U.S. stocks closed flat in a short session on Wednesday as investors found few reasons to push major indexes to their sixth straight day of gains despite strength in biotechs and bullish labor market data.

While both the S&P 500 and Dow touched intraday records, and the Dow closed at a slight record, the day's moves were slight and volume was light with many market participants already out for the Christmas holiday.

In a session that ended three hours early, about 2.5 billion shares traded on all U.S. platforms, according to BATS exchange data, well below the month-to-date average of 7.66 billion. Markets will reopen Friday.

Equities have been on a hot streak of late, with the Dow closing above 18,000 for the first time ever on Tuesday. The S&P 500 rose 5.5 percent over the past six sessions and has notched 51 closes this year, the most since 1995 and the fourth best in history.

Those gains have come on central bank assurances and improving economic data, a trend that continued with jobless claims on Wednesday. Initial claims for state unemployment benefits dropped 9,000 to a seasonally adjusted 280,000, their fourth straight week of declines, and below the forecast of 290,000.

"Equities are heading towards the year-end finale in a good position," said Terry Sandven, senior equity strategist at U.S. Bank Wealth Management in Minneapolis. "Fundamental and macro factors are supportive of higher equity prices, and clearly today if you look at the claims data which was generally in line with expectations, it still points toward an improving labor market."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Biotechs were the big gainers of the day, with the Nasdaq Biotech index (NBI) up 1.6 percent in a partial rebound from the drop of nearly 7 percent over the previous two sessions. Celgene Corp (O:CELG) rose 3.3 percent to $109.60 while Gilead Sciences (O:GILD) added 2 percent to $91.29.

The Dow Jones industrial average (DJI) rose 6.1 points, or 0.03 percent, to 18,030.27, the S&P 500 (SPX) lost 0.29 points, or 0.01 percent, to 2,081.88 and the Nasdaq Composite (IXIC) added 8.05 points, or 0.17 percent, to 4,773.47.

Both the Dow and S&P closed out their sixth straight daily advance, the longest streak for the benchmark S&P since June.

Energy shares continued their recent weakness as crude oil lost 3.5 percent to $55.15 per barrel and hovered near its lowest level since 2009. The S&P energy index <.SPNY> fell 0.8 percent; Exxon Mobil (N:XOM) lost 0.9 percent to $93.78 while ConocoPhillips (N:COP) slid 1.3 percent to $70.13.

Declining issues outnumbered advancing ones on the NYSE by 1,542 to 1,453, for a 1.06-to-1 ratio on the downside; on the Nasdaq, 1,550 issues rose and 1,090 fell for a 1.42-to-1 ratio favoring advancers.

The benchmark S&P 500 index was posting 78 new 52-week highs and 5 new lows; the Nasdaq Composite was recording 96 new highs and 24 new lows.

(Additional reporting by Chuck Mikolajczak; Editing by Meredith Mazzilli)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.